KALINA, T., M. BAKARDJIEVA, M. BLOM, M. PEREZ-ANDRES, B. BARENDREGT, V. KANDEROVA, C. BONROY, J. PHILIPPE, E. BLANCO, I. PICO-KNIJNENBURG, J. H. M. P. PAPING, B. WOLSKA-KUSNIERZ, M. PAC, J. TKAZCYK, F. HAERYNCK, H. H. AKAR, R. FORMANKOVA, Tomáš FREIBERGER, M. SVATORI, A. SEDIVA, S. ARRIBA-MENDEZ, A. ORFAO, J. J. M. VAN DONGEN a M. VAN DER BURG. EuroFlow Standardized Approach to Diagnostic Immunopheneotyping of Severe PID in Newborns and Young Children. Frontiers in Immunology. LAUSANNE: FRONTIERS MEDIA SA, 2020, roč. 11, MAR 2020, s. 1-14. ISSN 1664-3224. Dostupné z: https://dx.doi.org/10.3389/fimmu.2020.00371.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název EuroFlow Standardized Approach to Diagnostic Immunopheneotyping of Severe PID in Newborns and Young Children
Autoři KALINA, T. (203 Česká republika), M. BAKARDJIEVA (203 Česká republika), M. BLOM (528 Nizozemské království), M. PEREZ-ANDRES (724 Španělsko), B. BARENDREGT (528 Nizozemské království), V. KANDEROVA (203 Česká republika), C. BONROY (56 Belgie), J. PHILIPPE (724 Španělsko), E. BLANCO (724 Španělsko), I. PICO-KNIJNENBURG (528 Nizozemské království), J. H. M. P. PAPING (528 Nizozemské království), B. WOLSKA-KUSNIERZ (616 Polsko), M. PAC (616 Polsko), J. TKAZCYK (203 Česká republika), F. HAERYNCK (56 Belgie), H. H. AKAR (792 Turecko), R. FORMANKOVA (203 Česká republika), Tomáš FREIBERGER (203 Česká republika, domácí), M. SVATORI (203 Česká republika), A. SEDIVA (203 Česká republika), S. ARRIBA-MENDEZ (724 Španělsko), A. ORFAO (724 Španělsko), J. J. M. VAN DONGEN (528 Nizozemské království) a M. VAN DER BURG (528 Nizozemské království, garant).
Vydání Frontiers in Immunology, LAUSANNE, FRONTIERS MEDIA SA, 2020, 1664-3224.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30102 Immunology
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 7.561
Kód RIV RIV/00216224:14110/20:00116165
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.3389/fimmu.2020.00371
UT WoS 000525679400001
Klíčová slova anglicky flow cytometric immunophenotyping; primary immunodeficiencies (PID); EuroFlow; standardization; severe combined immune deficiency (SCID); diagnosis
Štítky 14110114, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 10. 8. 2020 10:59.
Anotace
The EuroFlow PID consortium developed a set of flow cytometry tests for evaluation of patients with suspicion of primary immunodeficiency (PID). In this technical report we evaluate the performance of the SCID-RTE tube that explores the presence of recent thymic emigrants (RTE) together with T-cell activation status and maturation stages and discuss its applicability in the context of the broader EuroFlow PID flow cytometry testing algorithm for diagnostic orientation of PID of the lymphoid system. We have analyzed peripheral blood cells of 26 patients diagnosed between birth and 2 years of age with a genetically defined primary immunodeficiency disorder: 15 severe combined immunodeficiency (SCID) patients had disease-causing mutations in RAG1 or RAG2 (n = 4, two of them presented with Omenn syndrome), IL2RG (n = 4, one of them with confirmed maternal engraftment), NHEJ1 (n = 1), CD3E (n = 1), ADA (n = 1), JAK3 (n = 3, two of them with maternal engraftment) and DCLRE1C (n = 1) and 11 other PID patients had diverse molecular defects [ZAP70 (n = 1), WAS (n = 2), PNP (n = 1), FOXP3 (n = 1), del22q11.2 (DiGeorge n = 4), CDC42 (n = 1) and FAS (n = 1)]. In addition, 44 healthy controls in the same age group were analyzed using the SCID-RTE tube in four EuroFlow laboratories using a standardized 8-color approach. RTE were defined as CD62L+CD45RO-HLA-DR-CD31+ and the activation status was assessed by the expression of HLA-DR+. Naive CD8+ T-lymphocytes and naive CD4+ T-lymphocytes were defined as CD62L+CD45RO-HLA-DR-. With the SCID-RTE tube, we identified patients with PID by low levels or absence of RTE in comparison to controls as well as low levels of naive CD4+ and naive CD8+ lymphocytes. These parameters yielded 100% sensitivity for SCID. All SCID patients had absence of RTE, including the patients with confirmed maternal engraftment or oligoclonally expanded T-cells characteristic for Omenn syndrome. Another dominant finding was the increased numbers of activated CD4+HLA-DR+ and CD8+HLA-DR+ lymphocytes. Therefore, the EuroFlow SCID-RTE tube together with the previously published PIDOT tube form a sensitive and complete cytometric diagnostic test suitable for patients suspected of severe PID (SCID or CID) as well as for children identified via newborn screening programs for SCID with low or absent T-cell receptor excision circles (TRECs).
VytisknoutZobrazeno: 14. 5. 2024 07:11